Key Events This Week
27 Jan: Stock hits 52-week low at Rs.375 amid ongoing downtrend
29 Jan: New 52-week low recorded at Rs.374.95; Q3 FY26 results reveal mounting losses
30 Jan: Week closes at Rs.408.20, up 4.09% for the week
Feb 06
BSE+NSE Vol: 2.75 k

Chemfab Alkalis Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 07 July 2025, reflecting a shift in the company’s outlook. However, the analysis and financial metrics discussed here are based on the stock’s current position as of 04 February 2026, providing investors with the latest insights into its performance and prospects.
Read full news article
27 Jan: Stock hits 52-week low at Rs.375 amid ongoing downtrend
29 Jan: New 52-week low recorded at Rs.374.95; Q3 FY26 results reveal mounting losses
30 Jan: Week closes at Rs.408.20, up 4.09% for the week
Chemfab Alkalis Ltd's latest financial results for Q3 FY26 indicate a company facing significant operational challenges. The net sales for the quarter were reported at ₹68.14 crores, reflecting a decline of 18.51% year-on-year and a sequential decrease of 11.00%. This marks the third consecutive quarter of falling sales, with cumulative revenue down 25.56% over the last two quarters. The company's net profit was a loss of ₹4.45 crores, a stark contrast to a profit of ₹3.64 crores in the same quarter last year, representing a substantial year-on-year decline. The operating margin also contracted sharply to 2.85%, down from 14.24% a year ago, indicating severe pricing pressures or cost inflation that the company has struggled to manage. Additionally, the operating profit before depreciation, interest, tax, and other income (PBDIT excluding other income) fell to ₹1.94 crores, the lowest in seven quarters, hi...
Read full news article
Chemfab Alkalis Ltd’s shares declined sharply to a fresh 52-week low of Rs.374.95 on 29 Jan 2026, marking a significant drop amid a sustained downtrend that has seen the stock underperform its sector and broader market indices over the past year.
Read full news article
Chemfab Alkalis Ltd., a micro-cap commodity chemicals manufacturer, reported a deeply concerning Q3 FY26 performance, with net losses widening to ₹4.45 crores—a staggering 336.70% deterioration compared to the ₹1.88 crores profit recorded in Q3 FY25. The Chennai-based caustic soda and chlorine producer has now posted consecutive quarterly losses, with operating margins collapsing to a mere 2.85%, down from 14.24% in the year-ago quarter. The stock plunged 7.66% following the results, trading at ₹379.35 and hovering perilously close to its 52-week low of ₹374.95.
Read full news article
Chemfab Alkalis Ltd, a player in the commodity chemicals sector, has touched a new 52-week low of Rs.375 today, marking a significant decline in its stock price amid ongoing downward momentum and underperformance relative to its sector and broader market indices.
Read full news article
Jan 19: Mixed technical signals amid continued pressure
Jan 20: Stock hits 52-week low of Rs.395.7
Jan 21: Further decline to new 52-week low of Rs.375.6
Jan 22: Sharp rebound with 5.99% gain to Rs.404.90
Jan 23: Week closes lower at Rs.392.15 (-3.15%)

Chemfab Alkalis Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 07 July 2025. However, the analysis and financial metrics discussed below reflect the stock's current position as of 24 January 2026, providing investors with an up-to-date view of the company’s performance and outlook.
Read full news article
Chemfab Alkalis Ltd’s shares declined sharply to a fresh 52-week low of Rs.395.7 on 20 Jan 2026, marking a significant milestone in the stock’s ongoing downward trajectory. The stock underperformed its sector and broader market indices, reflecting persistent pressures on the company’s financial performance and valuation metrics.
Read full news articleSubmission of newspaper clippings on publication of unaudited financial results for the quarter and nine months ended 31st December 2025
Submission of investor presentation for the quarter ended 31st December 2025
The Board meeting held today i.e. 28th January 2026 has approved the Un-Audited Standalone and Consolidated Financial Results for the quarter and nine months ended 31° December 2025 as recommended by the Audit committee at its meeting held earlier in the day.
No Upcoming Board Meetings
Chemfab Alkalis Ltd has declared 12% dividend, ex-date: 04 Sep 25
No Splits history available
No Bonus history available
No Rights history available